News and Announcements
Following a $15.5 million raise, Flamingo AI (ASX: FGO) begin commercialisation
- Published April 20, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Flamingo AI establishes foundation for long-term growth
- Commercialisation strategy commences
- Fortune 100 US Insurer Liberty Mutual goes live with Flamingo AI’s Virtual Assistant
- New Sales and Product executives hired – Sales strategy connected
Following the raising of $15.5 m in the previous Quarter, during Q3FY18 the Company has been highly active in shifting the focus of the business from product development to commercialisation. In addition to progressing existing clients, significant work has been conducted in establishing a strong sales and commercial capability to focus the Company on revenue generation.
To read the full ASX announcement, please click here.
About Flamingo AI (ASX: FGO)
Based in NYC and Sydney, Flamingo is an enterprise technology (SaaS) company in the emerging fields of Machine Learning and Conversational Commerce that helps businesses to automate online customer experiences for financial services. Flamingo provides a suite of AI powered Virtual Customer Assistants helping businesses to improve online sales conversion rates, customer experiences and reduce service costs. Our Virtual Customer Assistants, powered by Flamingo’s AI ‘ROSIE’ & ‘MAGGIE’, seamlessly combine chat, smart workflow, natural language processing and machine learning to automatically guide your customers through their online sales or service journey and help them to achieve what they set out to do. This means convenient, more personalised and faster online customer experiences.
Flamingo was acquired by ASX listed Cre8tek Limited in June 2016. The company’s ordinary shares are traded on the Australian Securities Exchange (ASX) under the ticker code CR8.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
